logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Agostino Gemelli University Policlinic

+390630151
direzione.scientifica@policlinicogemelli.it
Source: Site record.
https://www.policlinicogemelli.it

Claim This Site

Are you the site administrator? Claim this site to update information.

Basic Information

Site Overview

Source: Human-provided.

Agostino Gemelli University Policlinic is the largest hospital in Rome, the second-largest in Italy, and one of the largest private, non-profit academic medical centres in Europe. Founded in 1964 and located at Largo Agostino Gemelli 8, 00168 Rome, it serves as the official teaching hospital for the medical school of the Università Cattolica del Sacro Cuore. Spanning multiple specialized departments with 1,575 beds, it combines cutting-edge clinical care with groundbreaking scientific research, holding an official national designation as an IRCCS (research hospital) for Personalized Medicine and Innovative Biotechnology. It operates within the Italian national health system to provide free medical assistance while also managing an extensive international patient service and advanced private practice operations.

Business Status

Source: Human-provided. OPEN

Business Category

Source: Human-provided. University hospital

Business Subcategory

Source: Human-provided. University hospital
Source: Trial-derived.
413Total Trials
Source: Trial-derived.
146Recruiting Trials
Source: Trial-derived.
171Active Trials
Source: Trial-derived.
2Completed Trials
Source: Trial-derived.
641Unique Conditions
Source: Trial-derived.
315Unique Sponsors

Conditions

Source: Trial-derived. Breast Cancer (13)Source: Trial-derived. Ovarian Cancer (13)Source: Trial-derived. Endometrial Cancer (10)Source: Trial-derived. Duchenne Muscular Dystrophy (8)Source: Trial-derived. Atopic Dermatitis (7)Source: Trial-derived. HIV Infections (7)Source: Trial-derived. Cervical Cancer (6)Source: Trial-derived. Obesity (6)

Sponsors

Source: Trial-derived. Fondazione Policlinico Universitario Agostino Gemelli IRCCS (156)Source: Trial-derived. Hoffmann-La Roche (17)Source: Trial-derived. Bayer (14)Source: Trial-derived. Boehringer Ingelheim (13)Source: Trial-derived. Novo Nordisk A/S (9)Source: Trial-derived. Merck Sharp & Dohme LLC (8)Source: Trial-derived. Regeneron Pharmaceuticals (8)Source: Trial-derived. AbbVie (6)

Facilities & Operations

Facilities and operational capabilities inferred from trial participation

Source: AI-inferred. Overnight or inpatient research stays supported

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Telehealth study visits
Source: AI-inferred. Electronic data capture

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)
Source: AI-inferred. MRI
Source: AI-inferred. Optical coherence tomography (OCT)
Source: AI-inferred. Spirometry
Source: AI-inferred. CT Scan
Source: AI-inferred. MRI proton density fat fraction
Source: AI-inferred. Vibration-controlled transient elastography (FibroScan)
Source: AI-inferred. 12-lead ECG

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Timed pharmacokinetic sampling and processing
Source: AI-inferred. Histology / pathology
Source: AI-inferred. Immunogenicity (anti-drug antibody) testing
Source: AI-inferred. Pharmacokinetic bioanalysis
Source: AI-inferred. Specimen packaging and shipment
Source: AI-inferred. PCR / molecular

Research Pharmacy & Investigational Product

Investigational-product capabilities inferred from trial participation

Source: AI-inferred. Hazardous / cytotoxic drug handling
Source: AI-inferred. Sterile preparation (laminar-flow hood / BSC or cleanroom)

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Intravenous infusion administration
Source: AI-inferred. Endoscopy / colonoscopy
Source: AI-inferred. Intravitreal injection
Source: AI-inferred. Liver biopsy
Source: AI-inferred. Bone marrow biopsy
Source: AI-inferred. Cardiac catheterisation or electrophysiology procedures

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Tonometry
Source: AI-inferred. Visual acuity assessment
Source: AI-inferred. Brain imaging
Source: AI-inferred. Electronic patient-reported outcome (ePRO) system
Source: AI-inferred. Electronic patient-reported outcome collection
Source: AI-inferred. Electronic patient-reported outcome diary
Source: AI-inferred. Enhanced liver fibrosis testing
Source: AI-inferred. Fluorescein angiography